Economic evaluation of reproductive carrier screening for recessive genetic conditions: a systematic review.

Tianjiao Wang Mina Bahrampour Joshua M Byrnes Paul A Scuffham Edwin P Kirk Martin J Downes

Published in: Expert review of pharmacoeconomics & outcomes research (2021)

Establishing a validated and practical clinical strategy of RCS and investigating the cost-effectiveness of multiple conditions in one economic evaluation are critical for implementing RCS in the future. Further economic evaluations are essential to provide evidence-based practice for decision-makers.

Keyphrases

genome wide
current status
intellectual disability
quality improvement
gene expression
autism spectrum disorder